Streptomyces platensis (strain NRRL 18993), a producer of dorrigocins, was shown to produce migrastatin, a cyclic congener of dorrigocin A previously reported from a different organism. Additionally a new compound isomeric to migrastatin, isomigrastatin, was also isolated and its structure was determined to be a cyclic form of dorrigocin B. Both compounds were fully characterized from MS and NMR data. Product titers of both were improved by the addition of XAD-16 resin to the fermentation medium.
Development of a treatment to prevent the metastasis of tumor cells is essential to stopping tumor dissemination1).
One potential therapeutic agent is migrastatin (Fig. 1) , a non-cytotoxic glutarimide-containing compound possessing a 14-membered lactone ring, which has been reported to inhibit in vitro migration of human esophageal cancer EC17 cells and mouse melanoma B16 cells2,3). Migrastatin was first isolated from cultures of Streptomyces sp.
MK929-43F12).
Streptomyces platensis produces the dorrigocins (Fig. 1) , which are isomeric acyclic compounds derivable from migrastatin4,5). While S. platensis has not previously been reported to produce migrastatin, because of its structural similarities to dorrigocin A, we believed that S. platensis may also produce migrastatin (Fig. 1 ). Here we show that S. platensis does indeed produce migrastatin, as well as a new related compound isomigrastatin, a cyclic form of dorrigocin B. The production, purification, and characterization of migrastatin and isomigrastatin from fermentations of S. platensis are described.
Materials and Methods
General DRX 400 spectrometer equipped with a QNP z-axis 7.26 and 77.0 for 1H and 13C spectra, respectively. Cultures were screened for metabolite production on a PESciEx potential was 120V The spray tip potential was 5400V for positive ion, and -4500V for negative ion measurements. Dansyl-Gly-Trp was used as a mass standard internal to the samples.
Strains and Culture Conditions
Streptomyces platensis NRRL 18993 was used for this work. Cell banks were prepared by adding glycerol (30% v/v final concentration) to a culture growing exponentially in inoculum medium and then freezing 1ml samples at flour (Giusto's Vita-Grain), 1g/liter yeast extract (Sigma), 1g/liter NaCl, and 1g/liter CaCO3 in deionized water. The pH was adjusted to 7.0 with 2.5N NaOH and the medium sterile glucose solution (500g/liter) was added to give a final concentration of 13.6g/liter. Production medium4) contained 100g/liter XAD-16 (Amberlite), 20g/liter soy flour, 1g/liter yeast extract, and 2g/liter CaCO3. The pH was adjusted to 7.0 with 2.5N NaOH and the medium was glucose solution (500g/liter) was added to give a final concentration of 18.2g/liter. One cell bank vial was used to inoculate 50ml of inoculum medium in a 250ml baffled flask. The culture was allowed to grow for 2-3 days at 250 A portion (15.4g) of the solids was dissolved with 250ml of MeOH, and the mixture was stirred at room temperature for two hours. This suspension was filtered and diluted to C18 column that had been equilibrated with 50% MeOH.
The column was washed with 50% MeOH and eluted with 60% MeOH. production medium seemed to stabilize the structurally similar compounds dorrigocin A and B in culture broth. To assess whether XAD-16 resin had a similar stability affect on migrastatin, an XAD resin study was performed in shake flasks examining the effects of 5, 10, 20, 50, and 100g/liter XAD-16 on production titers (Fig. 2) . Although XAD-16 is reported here, other hydrophobic resins (e.g., HP20, Mitsubishi) demonstrated similar effects (data not shown). Fig. 2 shows that the addition of 100g/liter XAD-16, as compared to 5g/liter XAD-16, to the production medium increased isomigrastatin titers tenfold and migrastatin titers by 15%. In subsequent large scale fermentations, use of 100g/liter XAD-16 was consistently found to have a stimulatory effect on production, probably through a stability effect on the migrastatin and isomigrastatin6). It is also possible that the migrastatins are toxic to the cells above a certain level, and thus sequestering the compounds from the broth increases titers7). XAD-16 may also bind certain nutrients in the fermentation broth and thus influence secondary metabolism8).
Migrastatin and isomigrastatin were produced in similar ratios in the 10-liter and 150-liter fermentations. Production of the migrastatins reached a maximum on day 7 in the 150-liter fermentation (Fig. 3) . The culture was harvested from the 150-liter fermentation on day 9.
Structure Elucidation of Isomigrastatin
Isomigrastatin was purified from approximately half of Arrows point from protons to carbons.
